Bioanalytical Systems, Inc.
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Sep 30, 2010
Total Revenue 22,068 28,208 33,144 28,781
Cost of Revenue 15,013 21,370 22,638 21,448
Gross Profit 7,055 6,838 10,506 7,333
Operating Expenses
Research and Development 454 542 534 546
Sales, General and Admin. 5,771 8,787 8,685 8,784
Non-Recurring Items - 3,195 - -
Other - - - -
Operating Income 830 (5,686) 1,287 (1,997)
Income From Continuing Operations
Add'l Income/Expense Items 608 85 1,771 1
Earnings Before Interest and Tax 1,438 (5,601) 3,058 (1,996)
Interest Expense 649 714 706 1,028
Earnings Before Tax 789 (6,315) 2,352 (3,024)
Income Tax 16 2 50 (333)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 773 (6,317) 2,302 (2,691)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 773 (6,317) 2,302 (2,691)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 773 (6,317) 2,302 (2,691)